secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001575872-23-000629
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition amends stock purchase agreement; Estrella to issue 250K preferred shares as commitment fee
--------------------------------------------------------------------------------

- Amendment to Common Stock Purchase Agreement with White Lion Capital, dated April 26, 2023.
- Commitment fee changed: Estrella Biopharma to issue 250,000 Series A preferred shares ($250,000 value) to White Lion immediately prior to merger closing.
- Amendment modifies Sections 7.1(v) and 10.1(ii) of the original agreement; all other terms unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000629/0001575872-23-000629-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000629/uptd-20230426.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000629

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer